Related by context. All words. (Click for frequent words.) 76 PARP inhibitors 72 Olaparib 72 poly ADP ribose polymerase 71 proteasome inhibitor 71 Pertuzumab 71 olaparib 71 pertuzumab 70 MEK inhibitor 70 regorafenib 70 vascular disrupting agents 70 Onconase 69 Tyrima 69 mertansine 69 Zolinza 69 tyrosine kinase inhibitor 69 BRAF inhibitor 69 proteasome inhibitors 69 OMP #M# 69 Tarvacin 68 HER2 receptor 68 HSP# inhibitor 68 protein kinase inhibitor 68 erlotinib Tarceva ® 68 MEK inhibitors 68 BAY #-# 68 targeted radiotherapeutic 68 HQK 68 trastuzumab Herceptin 68 humanized monoclonal antibody 68 OncoVEX GM CSF 68 angiogenesis inhibitor 68 cilengitide 68 PLX# 68 GW# [003] 68 Daclizumab 67 DNA intercalator 67 AEG# 67 orally bioavailable 67 molecularly targeted 67 bevacizumab Avastin ® 67 Irinotecan 67 Anacetrapib 67 gamma secretase inhibitor 67 Pemetrexed 67 pan HDAC inhibitor 67 epothilones 67 vascular disrupting agent 67 thalidomide Thalomid 67 TG# [003] 67 metastatic colorectal 67 Neuvenge 67 Mipomersen 67 Panzem 67 IAP inhibitor 67 gefitinib Iressa 67 axitinib 67 mTOR inhibitors 67 receptor tyrosine kinase inhibitor 67 MORAb 67 Aliskiren 67 Aflibercept 67 antisense oligonucleotide 67 Xanafide 66 histone deacetylase inhibitor 66 ENMD # 66 JAK inhibitor 66 chimeric monoclonal antibody 66 SERMs 66 CBLC# 66 PARP inhibition 66 Aplidin 66 orally dosed 66 cediranib 66 preclinically 66 CCR5 antagonist 66 PDE4 inhibitor 66 vorinostat 66 Vorinostat 66 ATL# [001] 66 multi kinase inhibitor 66 depsipeptide 66 BMS # 66 dasatinib Sprycel 66 ixabepilone 66 selective androgen receptor modulator 66 Cloretazine 66 Azedra 66 PSMA ADC 66 OMP #R# 66 protein kinase inhibitors 66 anticancer agents 66 CDDO Im 66 flavopiridol 66 iniparib 66 enzastaurin 66 huN# DM1 66 TRO# 66 integrase inhibitor 66 phase IIb clinical 66 therapeutic monoclonal antibody 66 antisense drug 66 DFMO 66 IMA# 66 humanised monoclonal antibody 66 Crizotinib 66 Vandetanib 66 JAK inhibitors 66 Carfilzomib 66 Boceprevir 65 immunomodulator 65 sorafenib Nexavar 65 Vidofludimus 65 multikinase inhibitor 65 LY# [002] 65 enzyme inhibitor 65 JAK3 65 Atrasentan 65 Hycamtin 65 Dacogen decitabine 65 PI3K inhibitor 65 MAGE A3 ASCI 65 HDAC inhibitor 65 neratinib 65 renin inhibitors 65 Erbitux cetuximab 65 midstage trials 65 anti angiogenic agent 65 Davanat 65 mTOR inhibitor 65 Exemestane 65 vinca alkaloid 65 Ixempra 65 Factor VIIa 65 KSP inhibitor 65 tipifarnib 65 histone deacetylase HDAC inhibitor 65 VEGF receptor 65 IAP inhibitors 65 Pradefovir 65 tremelimumab 65 histone deacetylase HDAC inhibitors 65 Enzastaurin 65 CCX# 65 AEGR 65 HepDirect prodrug 65 factor Xa 65 farletuzumab 65 Trabectedin 65 HDACi 65 Dasatinib 65 oral prodrug 65 YONDELIS 65 antibody MAb 65 Smac mimetics 65 kinase inhibitor 65 monoclonal antibody MAb 65 alpha folate receptor 65 Proxinium TM 65 Sym# 65 Gleevec resistant 65 metaglidasen 65 IgG1 monoclonal antibody 65 liposomal formulation 65 personalized immunotherapy 65 radiation sensitizer 65 ganetespib 64 insulin sensitizers 64 humanized antibody 64 Abiraterone acetate 64 ErbB3 64 inhibit EGFR 64 Sorafenib 64 Tarvacin TM 64 Imprime PGG 64 IGF 1R inhibitor 64 endostatin 64 XmAb# 64 Tumor Necrosis Factor 64 Apixaban 64 multitargeted 64 HCV protease inhibitors 64 PXD# 64 Ixabepilone 64 gastrointestinal stromal tumors GIST 64 Gefitinib 64 investigational protease inhibitor 64 anti CD3 64 Omacetaxine 64 HuLuc# 64 Phase IIb clinical trials 64 CDK inhibitor 64 drug conjugate 64 PEP# [003] 64 EGF receptor 64 cathepsin K inhibitor 64 M2 subunit 64 Nanobody 64 Nexavar sorafenib 64 Zybrestat 64 erlotinib Tarceva 64 lapatinib Tykerb 64 Symadex 64 LY# [003] 64 bevacizumab Avastin 64 alkylating agent 64 targeting CD# 64 FLT3 64 Bezielle 64 brivanib 64 Gleevec imatinib mesylate 64 anticancer agent 64 selective kinase inhibitor 64 FK# 64 anti CD3 antibody 64 non nucleoside 64 Aurora kinase inhibitor 64 Epidermal Growth Factor Receptor 64 JAK2 inhibitor 64 MGd 64 malignant ascites 64 Phase #b/#a clinical 64 antitumor 64 Bortezomib 64 antiproliferative effects 64 trans retinoic acid 64 Vidaza azacitidine 64 Anticalin R 64 decitabine 64 FGFR1 64 Telcyta 64 thymalfasin 64 Tykerb lapatinib 64 dexpramipexole 64 BRCA deficient 64 PKCi 64 imatinib Gleevec 64 IL# PE#QQR 64 antimetabolite 64 Nexavar ® 64 A3 adenosine receptor 64 exemestane Aromasin 64 IgG1 antibody 64 oncolytic 64 gamma secretase inhibitors 64 volociximab 64 HCV protease inhibitor 64 ZACTIMA 64 nucleoside analog 64 Darusentan 64 Epirubicin 64 taxane chemotherapy 64 T#I [002] 64 Annamycin 64 deforolimus 64 OncoVEX 64 corticosteroid dexamethasone 64 ProMune 64 GRN# 64 Angiocept 64 Tesmilifene 64 Debio 64 Lapatinib 64 EGFR inhibitors 64 AMN# [001] 64 Traficet EN 64 huC# DM4 64 CYC# 64 OvaRex 64 VA# [002] 63 Aurora Kinase 63 gemcitabine Gemzar 63 PKC# 63 CXCR4 receptor 63 Amplimexon 63 BiPar 63 CD# monoclonal antibody 63 histone deacetylase inhibitors 63 bortezomib Velcade 63 Sapacitabine 63 mTOR mammalian target 63 canagliflozin 63 Maribavir 63 vemurafenib 63 cancer immunotherapies 63 CCR1 63 Muraglitazar 63 VEGF inhibitors 63 lumiliximab 63 Amrubicin 63 beta 1a 63 chemoresistance 63 pomalidomide 63 Erlotinib 63 talabostat 63 Litx 63 investigational humanized monoclonal antibody 63 Ataluren 63 selective androgen receptor modulators 63 Sphingomab 63 imatinib Gleevec ® 63 HuMax EGFr 63 kinase inhibitors 63 Velcade bortezomib 63 entinostat 63 chemically modified siRNA 63 trastuzumab Herceptin ® 63 Ceflatonin 63 nonsmall cell lung cancer 63 Romidepsin 63 TLR9 agonists 63 non nucleoside inhibitor 63 VitiGam 63 CYT# potent vascular disrupting 63 Degarelix 63 virotherapy 63 Archexin 63 Panzem R NCD 63 BRAF mutation 63 Fx #A 63 INCB# [001] 63 bendamustine 63 Phase Ib clinical 63 kinase inhibition 63 Herceptin trastuzumab 63 HCV protease 63 Virulizin ® 63 Phenoxodiol 63 oxidative stress inducer 63 lenalidomide Revlimid 63 alvespimycin 63 DCVax R 63 orally administered inhibitor 63 IMC A# 63 Temsirolimus 63 interferon IFN 63 docetaxel Taxotere R 63 K ras mutations 63 IGF 1R 63 temsirolimus 63 hedgehog pathway 63 DU #b 63 RhuDex ® 63 integrase inhibitors 63 mapatumumab 63 BRAF inhibitors 63 nucleoside reverse transcriptase inhibitor 63 anticancer compound 63 Troxatyl 63 CA4P 63 Trastuzumab 63 Squalamine 63 murine monoclonal antibody 63 sphingosine 1 63 EGFR tyrosine kinase inhibitors 63 atacicept 63 Panzem NCD 63 EGFR mutation 63 abiraterone 63 JAK2 inhibitors 63 vidofludimus 63 inhibit metastasis 63 AKT inhibitor 63 Fc fusion protein 63 Seliciclib 63 molecularly targeted therapy 63 oral proteasome inhibitor 63 Angiolix 63 Allovectin 7 ® 63 Darapladib 63 cetuximab Erbitux 63 PNP inhibitor 63 Genentech Herceptin 63 Varespladib 63 TLR9 agonist 63 galiximab 63 tyrosine kinase inhibitors 63 ALK inhibitors 63 Monoclonal antibody 63 Elvitegravir 63 gemcitabine carboplatin 63 novel histone deacetylase 63 chemopreventive agent 63 HER1 63 tafamidis 63 obatoclax 63 PTK# 63 tubulin inhibitor 63 favorable pharmacokinetic profile 63 sodium glucose cotransporter 63 Cannabinor 63 small molecule inhibitors 63 humanised antibody 63 Deforolimus 63 Abiraterone 63 Allovectin 7 63 Imatinib mesylate 63 potent antiproliferative 63 antiangiogenic agent 63 chemokine receptor 63 reslizumab 63 novel peptide 63 Guanilib 63 INGN 63 HER2 positive metastatic breast 63 NeuVax 63 antibody trastuzumab 63 echinocandin 63 neuroprotectant 63 Sorafenib Nexavar 63 SU# [003] 63 SAR# [002] 62 StemEx 62 Triapine 62 specific lectin receptors 62 oral anticancer 62 Hedgehog inhibitor 62 triphendiol 62 antibody fragment 62 Dapagliflozin 62 proteasome inhibitor bortezomib 62 superficial bladder cancer 62 angiogenesis inhibitors 62 Azixa 62 pegylated liposomal doxorubicin 62 targeted antifolate 62 carfilzomib 62 PF # [002] 62 AQ4N 62 DEB# 62 ErbB2 positive 62 anticancer therapy 62 Phase Ib clinical trials 62 BZL# 62 oral antiviral 62 MetMAb 62 isoform selective 62 docetaxel Taxotere 62 abiraterone acetate 62 Bleomycin 62 polymerase inhibitor 62 generation antisense 62 hormone LHRH antagonist 62 NF kB pathway 62 atrasentan 62 cytokine refractory 62 soluble receptor 62 selective inhibition 62 CD#L 62 virus HCV protease inhibitor 62 adalimumab Humira 62 PI3K/Akt pathway inhibitor 62 chemotherapeutic agent 62 OHR/AVR# 62 uPA 62 immunotherapeutic agent 62 milatuzumab 62 dasatinib Sprycel ® 62 Zarnestra 62 SGLT2 62 SCH # 62 paclitaxel Taxol 62 Doxil 62 commercialize deforolimus 62 Panzem R 62 BCR ABL 62 MAGE A3 62 Arranon 62 WT1 62 DHFR 62 Trastuzumab DM1 62 phase IIa clinical 62 relapsed ovarian cancer 62 2DG 62 IMiD 62 IFN α 62 GSK# [002] 62 Factor Receptor 62 ADI PEG 62 EGFr 62 riociguat 62 signal transduction inhibitor 62 Maraviroc 62 relapsed MM 62 tumor antigen 62 Bavituximab 62 etanercept Enbrel 62 Mpex 62 vinca alkaloids 62 Vicinium TM 62 Cytochrome P# 62 inhibitor RG# 62 EOquin 62 NNRTIs 62 GRN#L 62 Gemzar gemcitabine 62 Mitomycin C 62 Hsp# Inhibitor 62 CEQ# 62 sorafenib tablets 62 tumor vascular disrupting 62 metastatic malignant 62 PRT# 62 Phase IIa trials 62 Hsp# inhibition 62 antisense inhibitor 62 rNAPc2 62 PEGylated interferon 62 Talabostat 62 imetelstat 62 HDAC Inhibitor 62 trastuzumab DM1 62 Epratuzumab 62 HGS ETR1 62 cetuximab Erbitux ® 62 JAK1 62 evaluating tivozanib 62 metastatic renal cell carcinoma 62 anticoagulant reversing agent 62 L BLP# 62 endocrine therapies 62 AMPK activators 62 bleomycin 62 TriRima 62 immunoconjugate 62 PEG SN# 62 elvitegravir 62 cytotoxin 62 VEGF inhibitor 62 AGTR1 62 Peginterferon 62 Saxagliptin 62 ADP receptor antagonist 62 chemoresistant 62 RNAi therapeutic targeting 62 immunotherapeutic vaccine 62 selective agonist 62 Aurora kinase 62 thiazolides 62 Laquinimod 62 IGFBP2 62 Vilazodone 62 cytostatic 62 MUC1 * 62 Lenalidomide 62 recurrent NSCLC 62 Blinatumomab 62 GLPG# 62 Fenretinide 62 IGF IR 62 mesothelin 62 EZN 62 letrozole Femara 62 anti angiogenic agents 62 TLR8 agonist 62 LHRH receptor positive 62 anti angiogenic therapy 62 CCR9 62 fusion protein 62 EOquin TM 62 synthetic peptide 62 teplizumab 62 MAb 62 ocrelizumab 62 oncolytic vaccine 62 DXL# 62 CCR2 62 anti angiogenic 62 Protease inhibitors 62 angiogenesis inhibition 62 Taxol ® 62 ToGA 62 assessing T DM1 62 HyperAcute 62 midstage clinical trials 62 Rituxan rituximab 62 visilizumab 62 sulindac 62 myeloproliferative disorders 62 colorectal carcinoma 62 Antiangiogenic 62 ISIS # 62 Kinase Inhibitor 62 engineered RAP peptides 62 histone deacetylase HDAC 62 PDGF receptor 62 insulin sensitizing 62 Pegylated Interferon 62 RhuDex R 62 topoisomerase 62 antiangiogenesis 62 Pharmacokinetics PK 62 cytoprotective 62 CCR9 antagonist 62 small molecule tyrosine 62 brostallicin 62 Tofacitinib 62 Aviptadil 61 cisplatin chemotherapy 61 Afatinib 61 IGF1R 61 torezolid 61 etoposide 61 dexamethasone Decadron 61 sunitinib malate 61 oncoprotein 61 trabectedin 61 5 Fluorouracil 61 IRX 2 61 Estrogen Receptor 61 azacytidine 61 Voreloxin 61 Ridaforolimus 61 gastrointestinal stromal tumors 61 Epothilones 61 AZD# 61 chemotherapeutic drug 61 LAF# 61 PSN# [002] 61 Perifosine 61 Omnitarg 61 trastuzumab Herceptin R 61 nab paclitaxel 61 pegylated interferons 61 chemotherapeutics 61 CDP# 61 tubulin binding 61 Fodosine 61 microtubule inhibitor 61 natriuretic peptide 61 Thrombin 61 siRNA therapeutic 61 Arimoclomol 61 aurora kinase inhibitor 61 somatostatin receptors 61 cyclin dependent kinase inhibitor 61 TOCOSOL Camptothecin 61 immunotherapeutic 61 Onrigin 61 polymerase inhibitors 61 IMC #B 61 aflibercept VEGF Trap 61 Anticalin 61 Fluorouracil 61 midstage clinical 61 TACI Ig 61 REP# 61 OncoVex 61 teriflunomide 61 mitotic kinesins 61 sargramostim 61 Multimeric 61 E#F# 61 OvaRex ® MAb 61 castrate resistant prostate cancer 61 elotuzumab 61 GPNMB 61 Pimavanserin 61 HCV NS5B polymerase 61 retinoic acid receptor 61 Curaxin 61 HDACs 61 THR beta agonist 61 anticancer therapeutics 61 Eribulin 61 ZOLINZA 61 SARMs 61 Reverset 61 BrachySil 61 receptor blocker 61 Trofex 61 Campath alemtuzumab 61 ErbB2 61 highly selective endothelin 61 Campath ® 61 oral ridaforolimus 61 Cytoxan 61 mda 7 61 PORxin TM 61 relapsed leukemia 61 Bucindolol 61 glucagon receptor 61 signal transduction inhibitors 61 NEUGENE 61 PARP Inhibitor 61 AP# [003] 61 RGB # 61 Phase 2b clinical trials 61 HIV protease 61 vWF 61 R#/MEM # 61 E2F 61 cetuximab Erbitux R 61 nanopharmaceutical 61 nucleoside analogue 61 Melphalan 61 Everolimus 61 liposomal doxorubicin 61 nucleotide analogue 61 pDCs 61 EGFR receptor 61 NXL# 61 Rigel R# 61 romidepsin 61 pegfilgrastim 61 NPC 1C 61 dacetuzumab 61 Torisel 61 phase IIb trial 61 drug zotarolimus 61 TLR8 61 refractory chronic lymphocytic 61 Sutent sunitinib 61 rituximab Rituxan 61 preclinical efficacy 61 GV# [001] 61 antifibrotic 61 ASONEP 61 cMET 61 lexidronam injection 61 Raltegravir 61 selective inhibitors 61 reversible inhibitor 61 Galectin 3 61 Cisplatin 61 mutational status 61 Glufosfamide 61 TransMID 61 pediatric acute lymphoblastic 61 c Raf kinase 61 CCR5 antagonists 61 cangrelor 61 aurora kinase 61 HIV integrase inhibitor 61 fosbretabulin 61 tolevamer 61 potent inhibitor 61 Telatinib 61 erythropoietic 61 LBH# 61 antifolate 61 syngeneic 61 Asentar 61 Fibroblast Growth Factor Receptor 61 L Annamycin 61 humanized monoclonal 61 potently inhibit 61 Interferon beta 61 Ontak 61 Ocrelizumab 61 Silodosin 61 KRN# 61 Ozarelix 61 Mepact 61 gastrointestinal stromal tumors GISTs 61 EndoTAGTM 1 61 Factor VEGF 61 Bevacizumab 61 fenretinide 61 Bryostatin 61 leukemia AML 61 c MET 61 antitumor effects 61 ibritumomab tiuxetan 61 taxol 61 selective inhibitor 61 Sudhir Agrawal D.Phil 61 naturally occurring molecule 61 humanized monoclonal antibodies 61 EGFR pathway 61 delta isoform 61 Teriflunomide 61 pancreatic adenocarcinoma 61 Curaxin CBLC# 61 gemcitabine cisplatin 61 Neovastat 61 HGS# 61 ATL# [002] 61 Insegia 61 CB1 antagonists 61 combretastatin A4 phosphate CA4P 61 TPI ASM8 61 novel anticancer 61 Her2 61 LHRH antagonist 61 HER2/neu 61 Bafetinib 61 Eli Lilly Gemzar 61 malignant pleural mesothelioma 61 anticancer therapies 61 refractory metastatic 61 2 methoxyestradiol 61 ART# 61 Ipilimumab 61 PI3 kinase 61 Doxorubicin 61 Kevetrin ™ 61 cholesteryl ester transfer 61 immunomodulating 61 Tanespimycin 61 anti CD# antibodies 61 induces apoptosis 61 vismodegib 61 daclizumab 61 basiliximab 61 small molecule chemotherapeutic 61 tarenflurbil 61 MyVax R 61 Cloretazine ® 61 hormone gastrin 61 acyclovir Lauriad R 61 MYDICAR ® 61 selective estrogen receptor 61 HCV replicon 60 MyVax 60 RhuDex TM 60 mycophenolate mofetil 60 Cetuximab Erbitux 60 monoclonal anti 60 Pazopanib 60 cortisol receptor 60 GSK '# 60 polysaccharide polymer 60 anti mitotic 60 Tumour Vascular Disrupting Agent 60 receptor antagonists 60 luteinizing hormone releasing 60 amrubicin 60 BRAF kinase 60 ALK inhibitor 60 beta interferons 60 antisense inhibitors 60 ocular formulation 60 Aurora kinase inhibitors 60 immune modulating 60 TLR antagonist 60 adenoviral 60 Syk kinase 60 platelet inhibitor 60 Alemtuzumab 60 relapsed multiple myeloma 60 nucleoside analogues 60 CETP inhibitor 60 Fludarabine 60 TREANDA 60 CDK4 60 S#P# 60 SNT MC# 60 GeneICE 60 TLK# 60 Etoposide 60 anti fibrotic 60 defensin mimetic antibiotic 60 nucleotide analog 60 exon skipping 60 Personalized Immunotherapy 60 AEZS 60 mineralocorticoid receptor 60 Allovectin 7 R 60 hematological cancers 60 5FU 60 PROCHYMAL 60 Panitumumab 60 selective immunoproteasome inhibitor 60 HuMax CD4 60 indibulin 60 investigational monoclonal antibody 60 Nanobody ® 60 eIF 4E 60 taxane 60 Vitaxin 60 GRNVAC1 60 immunomodulatory 60 taxanes 60 immunosuppressant 60 potent anticancer 60 alpha#beta# integrin 60 mutated K ras 60 S/GSK# 60 oral Azacitidine 60 PEGylated Fab fragment 60 SGS# 60 receptor modulators 60 HER-2/neu 60 EndoTAG TM -1 60 Gemcitabine 60 epigenetic therapies 60 5 fluorouracil leucovorin 60 chemotherapy cisplatin 60 Temozolomide 60 HDAC inhibitors 60 docetaxel Taxotere ® 60 CIMZIA ™ 60 Taxol paclitaxel 60 EGFRvIII 60 PANVAC VF 60 bicalutamide 60 TNF Tumor Necrosis Factor 60 HER2 positive cancers 60 Lodamin 60 immune stimulatory 60 PKM2 60 Cetuximab 60 JAK3 inhibitor 60 MDS AML 60 radiolabeled 60 Preclinical studies suggest 60 nab docetaxel 60 somatostatin analogue 60 peritoneal carcinomatosis 60 PrevOnco 60 tumor hypoxia 60 MUC1 60 DNA methyltransferases 60 PhG alpha 1 60 ispinesib SB # 60 protein tyrosine phosphatase 1B 60 miRview mets 60 SUTENT 60 tanespimycin 60 JAK2 60 Imatinib 60 HER3 60 LymphoStat B belimumab 60 tranilast 60 ara C 60 B Raf 60 DAPT 60 ADAMTS# 60 Doxil ® 60 alefacept 60 investigational hepatitis C 60 nilotinib Tasigna ® 60 IDH1 60 BLP# Liposome Vaccine 60 CIMZIA TM 60 Carboplatin 60 PD LID 60 forodesine 60 acetonide FA 60 c MYC 60 Arcalyst 60 VEGFR2 60 intestinal polyps 60 Glioblastoma Multiforme 60 IMP# 60 PI3K inhibitors 60 BiTE 60 mouse xenograft models 60 multicenter Phase II 60 Enzyme Replacement Therapy 60 azoles 60 PI3K/mTOR 60 lomitapide 60 HAAH 60 Cellcept 60 reverse transcriptase inhibitors 60 Lpathomab 60 tyrosine kinase receptor 60 HuMax CD# 60 TLR agonists 60 NV1FGF 60 xenograft models 60 telomerase inhibitor 60 TKI therapy 60 PNT# 60 Genentech Roche 60 CXCR7 60 antitumoral 60 panitumumab Vectibix 60 Hsp# inhibitors 60 ISF# 60 immunotoxin 60 PRTX 60 PSN# [001] 60 binds selectively 60 Theratope 60 Hedgehog pathway 60 radiolabeled monoclonal antibody 60 chemotherapeutic agents 60 XYOTAX TM 60 Taxotere docetaxel 60 medullary thyroid cancer 60 MKC# MKC# PP 60 DPP4 inhibitor 60 MKC# MT 60 Elotuzumab 60 CD# antibody [001] 60 cytochrome P# 60 INC# 60 Preclinical studies 60 elacytarabine 60 transcriptase inhibitors NNRTIs 60 TBC# 60 RNA antagonist 60 anti PlGF 60 Exherin TM 60 INCB# [003] 60 Safinamide 60 triterpenoids